Drugstore group Walgreens reported that sales declined 3.4% to $17.8bn (£11.4bn) for the third quarter ended May 31.
Net earnings fell by 10.8% to $537m (£345m), impacted by the retailer no longer being part of the Express Scripts pharmacy provider network, as well as costs associated with entering into a strategic transaction with Alliance Boots.
Walgreens president and chief executive Greg Wasson said: “We continue to learn from our 200 pilot Well Experience format stores. We also continue to advance the role of community pharmacy by expanding our pharmacy, health and wellness services.”
No comments yet